Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT00486460
Eligibility Criteria:
Inclusion Criteria:
* Locally advanced or metastatic adenocarcinoma of the pancreas, confirmed by histology or cytology.
* No prior chemotherapy for pancreatic cancer.
* Performance status 0-2 (ECOG scale).
* Age ≥ 18 y.
* Adequate hematologic function (ANC ≥ 1500/mm³, platelet count ≥ 100,000/mm³).
* Adequate hepatic function (total bilirubin ≤ 2.0xUNL and AST, ALT and AP ≤ 5.0xUNL)
* Adequate renal function (creatinine ≤ 2.0).
* Signed informed consent.
Exclusion Criteria:
* A history of treated or active central nervous system involvement by the tumor or active neurological disease.
* Prior radiation. Patients with disease outside the irradiation field or documented disease progression of previously irradiated disease are eligible.
* Unstable medical condition, including uncontrolled diabetes mellitus or hypertension, active infection, unstable CHF, uncontrolled arrhythmias or unstable coagulation disorders.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00486460
Study Brief:
Protocol Section:
NCT00486460